The Immune Microenvironment in Chordoma: Implications for Future Treatment

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Chordoma is a rare, aggressive malignant mesenchymal tumor with high recurrence rates.
• Current treatments (surgery, radiotherapy, chemotherapy) have suboptimal efficacy due to complex locations and drug resistance.
• Advances in understanding the tumor immune microenvironment offer new avenues for chordoma immunotherapy.

Purpose of the Study:

• To systematically review recent research on the chordoma immune microenvironment.
• To elucidate the roles of tumor, immune, and stromal cells in chordoma progression.
• To provide a foundation for developing precise immunotherapies for chordoma.

Main Methods:

• Systematic literature review of studies on the chordoma immune microenvironment.
• Analysis of protumorigenic and antitumorigenic mechanisms of cellular components.
• Focus on interactions within the tumor microenvironment.

Main Results:

• The chordoma immune microenvironment comprises tumor cells, immune cells, and stromal cells.
• These cellular components exhibit both protumorigenic and antitumorigenic functions.
• Understanding these complex interactions is crucial for therapeutic development.

Conclusions:

• The chordoma immune microenvironment is a critical target for novel therapies.
• Further research into cellular mechanisms can guide the development of precise chordoma immunotherapies.
• Targeting the tumor immune microenvironment holds significant potential for improving chordoma treatment outcomes.